362 related articles for article (PubMed ID: 22374306)
1. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
Popovic S; Urbán E; Lukic M; Conlon JM
Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
[TBL] [Abstract][Full Text] [Related]
2. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
3. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
6. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.
Conlon JM; Sonnevend A; Pál T; Vila-Farrés X
Int J Antimicrob Agents; 2012 Apr; 39(4):317-20. PubMed ID: 22326566
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris.
Marta Guarna M; Coulson R; Rubinchik E
FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I; Nishijima S; Kawabata S
Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes.
Isard O; Lévêque M; Knol AC; Ariès MF; Khammari A; Nguyen JM; Castex-Rizzi N; Dréno B
Arch Dermatol Res; 2011 Dec; 303(10):707-13. PubMed ID: 21461892
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory and anti-inflammatory effects of two antimicrobial peptides moronecidin and temporin-1Dra against Propionibacterium acnes in vitro and in vivo.
Wu Y; Zhang G; Zhou M
J Pept Sci; 2020 Jul; 26(7):e3255. PubMed ID: 32567152
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.
Caillon F; O'Connell M; Eady EA; Jenkins GR; Cove JH; Layton AM; Mountford AP
Br J Dermatol; 2010 Feb; 162(2):296-303. PubMed ID: 19796181
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.
Ryu S; Park Y; Kim B; Cho SM; Lee J; Lee HH; Gurley C; Song K; Johnson A; Armstrong CA; Song PI
Br J Dermatol; 2014 Dec; 171(6):1358-67. PubMed ID: 25313444
[TBL] [Abstract][Full Text] [Related]
16. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria.
Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM
Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372
[TBL] [Abstract][Full Text] [Related]
17. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
Leyden JJ; Del Rosso JQ; Webster GF
Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
[TBL] [Abstract][Full Text] [Related]
19. Acne and Propionibacterium acnes.
Bojar RA; Holland KT
Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
